Autism and pain - A literature review;Autisme et douleur - analyse bibliographique

Pain Research and Management

Volumn 15, Issue 4, 2010, Pages 245-253

  Dubois, Amandine ^a   Rattaz, Cécile ^a   Pry, René ^a   Baghdadli, Amaria ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Assessment; Autism; Expression; Pain; Sensory

Indexed keywords

ANALGESIA; AUTISM; COMPLICATION; HUMAN; PAIN;

AUTISTIC DISORDER; HUMANS; PAIN; PAIN MANAGEMENT;

EID: 77956584648     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/749275     Document Type: Review

References (73)

1. Organisation mondiale de la santé. CIM 10, Classification statistique internationale des maladies et des problèmes de santé connexes - dixième révision. Genève: Organisation mondiale de la santé, 1993.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV - Text Revised. Washington: American Psychiatric Association, 2000.
3. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: An update. J Autism Dev Disord 2003;33:365-82.
4. Oberlander TF, Symons FJ. Pain in children and adults with developmental disabilities. Baltimore: Paul H Brookes Publishing, 2006.
5. Gillberg C, Coleman M. Autism and medical disorders: A review of the literature. Dev Med Child Neurol 1996;38:191-202.
6. Lee L, Harrington RA, Chang JJ, Connors SL. Increased risk of injury in children with developmental disabilities. Res Dev Disabil 2008;29:247-55.
7. Breau LM, Camfield CS, McGrath PJ, Finley GA. The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med 2003;157:1219-26.
8. Biersdorff KK. Pain insensitivity and indifference: Alternative explanations for some medical catastrophes. Ment Retard 1991;29:359-62.
9. Tordjman S, Antoine C, Cohen DJ et coll. Study of the relationships between self-injurious behavior and pain reactivity in infantile autism. Encephale 1999;25:122-34.
10. Tordjman S, Anderson GM, Botbol M et coll. Pain reactivity and plasma b-endorphin in children and adolescents with autistic disorder. PLoS ONE 2009;4:e5.
11. Militerni R, Bravaccio C, Falco C, Puglisi-Allegra S, Pascucci T, Fico C. Pain reactivity in children with autistic disorder. J Headache Pain 2000;1:53-6.
12. Gilbert-MacLeod CA, Craig KD, Rocha EM, Mathias MD. Everyday pain responses in children with and without developmental delays. J Pediatr Psychol 2000;25:301-8.
13. Pernon E, Rattaz C. Les modes d'expression de la douleur chez l'enfant autiste : Étude comparée. Devenir 2003;15:263-77.
14. Nader R, Oberlander TF, Chambers CT, Craig KD. Expression of pain in children with autism. Clin J Pain 2004;20:88-97.
15. Messmer RL, Nader R, Craig KD. Brief report: Judging pain intensity in children with autism undergoing venepuncture: The influence of facial activity. J Autism Dev Disord 2008;38:1391-4.
16. Breau LM, Finley GA, McGrath PJ, Camfield CS. Validation of the non-communicating children's pain checklist - postoperative version. Anesthesiology 2002;96:528-35.
17. Defrin R, Lotan M, Pick CG. The evaluation of acute pain in individuals with cognitive impairment: A differential effect of the level of impairment. Pain 2006;124:312-20.
18. Malviya S, Voepel-Lewis T, Burke C, Merkel S, Tait AR. The revised FLACC observational pain tool: Improved reliabillity and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth 2006;16:258-65.
19. Panksepp J. A neurochemical theory of autism. Trends Neurosci 1979;2:174-7.
20. Bouvard MP, Leboyer M, Launay JM et coll. Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study. Psychiatry Res 1995;58:191-201.
21. Cazzullo AG, Musetti MC, Musetti L, Bajo S, Sacerdote P, Panerai A. Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children. Eur Neuropsychopharmacol 1999;9:361-6.
22. Gillberg C, Terenius L, Lönnerholm G. Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases. Arch Gen Psychiatry 1985;42:780-3.
23. Leboyer M, Bouvard MP, Launay JM et coll. Brief report: A double-blind study of naltrexone in infantile autism. J Autism Dev Disord 1992;22:309-19.
24. Ross DL, Klykylo WM, Hitzemann R. Reduction of elevated CSF betaendorphin by fenfluramine in infantile autism. Pediatr Neurol 1987;3:83-6.
25. Sandman CA. The opiate hypothesis in autism and self-injury. J Child Adolesc Psychopharmacol 1991;1:237-48.
26. Sandman CA. Beta-endorphin dysregulation in autistic and self-injurious behavior: A neurodevelopmental hypothesis. Synapse 1988;2:193-9.
27. Campbell M, Anderson LT, Small AM, Adams P, Gonzalez NM, Ernst M. Naltrexone in autistic children: Behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry 1993;32:1283-91.
28. Herman BH, Hammock MK, Arthur-Smith A et coll. Role of opioid peptides in autism: Effects of acute administration of naltrexone. Soc Neurosci 1986;12:1172. (résumé)
29. Ernst M, Devi L, Silva RR et coll. Plasma betaendorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacol Bull 1993;29:221-7.
30. Hunter LC, O'Hare A, Herron WJ, Fisher LA, Jones GE. Opioid peptides and dipeptidyl peptidase in autism. Dev Med Child 2003;45:121-8.
31. Nagamitsu S, Matsuishi T, Kisa T et coll. CSF b-endorphin levels in patients with infantile autism. J Autism Dev Disord 1997;27:155-63.
32. Sandman CA, Barron JL, Chiez-DeMet A, DeMet EM. Brief report: Plasma b-endorphin and cortisol levels in autistic patients. J Autism Dev Disord 1991;21:83-7.
33. Gillberg C, Hagberg B, Witt-Engerstöm I, Eriksson I. CSF beta-endorphins in childhood neuropsychiatric disorders. Brain Dev 1990;12:88-92.
34. Weizman R, Weizman A, Tyano S, Szekely BA, Sarne YH. Humoralendorphin blood levels in autism in autistic, schizophrenic and healthy subjects. Psychopharmacologia 1984;82:363-70.
35. Weizman R, Gil-Ad I, Dick J, Tyano S, Szekely G, Laron Z. Low plasma immunoreactive beta-endorphin. J Am Acad Child Adolesc Psychiatry 1988;27:430-33.
36. Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BD. Autism and urinary exogenous neuropeptides: Development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal Bioanal Chem 2007;388:1643-51.
37. Symons FJ, Danov SE. A prospective clinical analysis of pain behavior and self-injurious behavior. Pain 2005;117:473-7.
38. Breau LM, Camfield CS, Symons FJ et coll. Relation between pain and self-injurious behavior in non-verbal children with severe cognitive impairments. J Pediatr 2003;142:498-503.
39. Symons FJ, Harper VN, McGrath PJ, Breau LM, Bodfish JW. Evidence of increased non-verbal behavioral signs of pain in adults with neurodevelopmental disorders and chronic self-injury. Res Dev Disabil 2009;30:521-8.
40. Symons FJ, Thompson T. Self-injurious behaviour and body site preference. J Intellect Disabil Res 1997;41:456-68.
41. Gillberg C. Endogeneous opioids and opiate antagonists in autism: Brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 1995;37:239-45.
42. Shattock P, Whiteley P. Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 2002;6:175-83.
43. Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: A review of the literature. Res Dev Disabil 2006;27:254-89.
44. Rutherford MD. A retrospective journal-based case study of an infant with autism and his twin. Neurocase 2005;11:129-37.
45. Merskey H, Bogduk N. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press, 1994.
46. Rogers SJ, Ozonoff S. Annotation: What do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry 2005;46:1255-68.
47. Pernon E, Pry R, Baghdadli A. Autism: Tactile perception and emotion. J Intellect Disabil Res 2007;51:580-7.
48. Dunn W, Westman K. The sensory profile: The performance of a national sample of children without disabilities. Am J Occup Ther 1997;51:25-34. (Pubitemid 127453175)
49. Tomchek SD, Dunn W. Sensory processing in children with and without autism: A comparative study using the short sensory profile. Am J Occup Ther 2007;61:190-200.
50. Rogers SJ, Hepburn S, Wehner E. Parent reports of sensory symptoms in toddlers with autism and those with other developmental disorders. J Autism Dev Disord 2003;33:631-42.
51. Crane L, Goddard L, Pring L. Sensory processing in adults with autism spectrum disorders. Autism 2009;13:215-28.
52. Ben-Sasson A, Hen L, Fluss R, Cermak SA, Engel-Yeger B, Gal E. A meta-analysis of sensory modulation symptoms in individuals with autism spectrum disorders. J Autism Dev Disord 2009;39:1-11.
53. Leekam SR, Nieto C, Libby SJ, Wing L, Gould J. Describing the sensory abnormalities of children and adults with autism. J Autism Dev Disord 2007;37:894-910.
54. Baranek GT, David FJ, Poe MD, Stone WL, Watson LR. Sensory experiences questionnaire: Discriminating sensory features in young children with autism, developmental delays, and typical development. J Child Psychol Psychiatry 2006;47:591-601.
55. Mottron L, Burack J. Enhanced perceptual functioning in the development of autism. Dans: Burack JA, Charman T, Yirmiya N, Zelazo PR, éd. The development of autism: Perspectives from theory and research. Mahwah: Erlbaum, 2001:131-48.
56. Grandin T. Emergence: Labeled Autistic. Novato: Arena Press, 1986.
57. O'Riordan M, Passetti F. Discrimination in autism within different sensory modalities. J Autism Dev Disord 2006;36:665-75.
58. Blakemore SJ, Tavassoli T, Calò S et coll. Tactile sensitivity in Asperger syndrome. Brain Cogn 2006;61:5-13.
59. Cascio C, McGlone F, Folger S et coll. Tactile perception in adults with autism: A multidimensional psychophysical study. J Autism Dev Disord 2008;38:127-37.
60. Fanurik D, Koh JL, Schmitz ML, Harrison RD, Conrad TM. Children with cognitive impairment: Parent report of pain and coping. J Dev Behav Pediatr 1999;20:228-34.
61. Voepel-Lewis T, Malviya S, Tait AR. Validity of parent ratings as proxy measures of pain in children with cognitive impairment. Pain Manag Nurs 2005;6:168-74.
62. Hadden KL, von Baeyer CL. Pain in children with cerebral palsy: Common triggers and expressive behaviors. Pain 2002;99:281-8.
63. Dubois A, Capdevila X, Bringuier S, Pry R. Pain in children with an intellectual disability. Eur J Pain 2010. (Sous presse)
64. Zabalia M. Pour une psychologie de l'enfant face à la douleur. Enfance 2006;1:5-19.
65. Hadjistavropoulos T, Craig KD. A theorical framework for understanding self-report and observational measures of pain: A communications model. Behav Res Ther 2002;40:551-70.
66. Johnston C, Stevens B. Experience in a neonatal intensive care unit affects pain response. Pediatrics 1996;98:925-30.
67. Herr K, Coyne PJ, Key T et coll. Pain assessment in the nonverbal patient: Position statement with clinical practice recommendations. Pain Manag Nurs 2006;7:44-52.
68. Breau LM, McGrath PJ, Camfield CS, Finley GA. Psychometric properties of the non-communicating children's pain checklist-revised. Pain 2002;99:349-57.
69. Collignon P, Giusiano B. Validation of a pain evaluation scale for patients with cerebral palsy. Eur J Pain 2001;5:433-42.
70. Hunt A, Goldman A, Seers K et coll. Clinical validation of the Paediatric Pain Profile. Dev Med Child Neurol 2004;46:9-18.
71. Symons FJ, Shinde SK, Gilles E. Perspectives on pain and intellectual disability. J Intellect Disabil Res 2008;52:275-86.
72. O'Neill RE, Horner RH, Sprague JR, Albin RW. Évaluation fonctionnelle et développement de programmes d'assistance pour les comportements problématiques : manuel pratique. Paris: De Boeck Université, 2008.
73. Bosch J, Van Dyke DC, Smith SM, Poulton S. Role of medical conditions in the exacerbation of self-injurious behavior: An exploratory study. Ment Retard 1997;35:124-30.